Topics in Pediatric Leukemia--acute Lymphoblastic Leukemia

Overview

Journal MedGenMed

Specialty General Medicine

Date 2005 Dec 22

PMID 16369328

Citations 23

Authors

Samuel D Esparza

Kathleen M Sakamoto

Affiliations

Soon will be listed here.

Citing Articles

Metabolomic insights into pathogenesis and therapeutic potential in adult acute lymphoblastic leukemia.

Wang J, Gui T, Jiao B, Liu X, Ma X, Wang C Proc Natl Acad Sci U S A. 2025; 122(7):e2423169122.

PMID: 39946534 PMC: 11848409. DOI: 10.1073/pnas.2423169122.

Expression of Growth Hormone-Releasing Hormone and Its Receptor Splice Variants in a Cohort of Hungarian Pediatric Patients with Hematological and Oncological Disorders: A Pilot Study.

Juhasz E, Szabo Z, Schally A, Kiraly J, Fodor P, Konya G Int J Mol Sci. 2024; 25(16).

PMID: 39201517 PMC: 11354965. DOI: 10.3390/ijms25168831.

Cytokine-induced killer cells: new insights for therapy of hematologic malignancies.

Ghanbari Sevari F, Mehdizadeh A, Abbasi K, Hejazian S, Raeisi M Stem Cell Res Ther. 2024; 15(1):254.

PMID: 39135188 PMC: 11321231. DOI: 10.1186/s13287-024-03869-z.

Effect of sustained measurable residue disease negativity and post-remission treatment selection on the prognosis of acute lymphoblastic leukemia in adults.

Yu J, Luo Y, Wang L, Wang T, Ye M, Chen J Cancer Med. 2024; 13(10):e7310.

PMID: 38785213 PMC: 11117453. DOI: 10.1002/cam4.7310.

Checkpoint Immunotherapy in Pediatric Oncology: Will We Say Checkmate Soon?.

Ciurej A, Lewis E, Gupte A, Al-Antary E Vaccines (Basel). 2023; 11(12).

PMID: 38140246 PMC: 10748105. DOI: 10.3390/vaccines11121843.

References

Pui C, Boyett J, Rivera G, Hancock M, Sandlund J, Ribeiro R . Long-term results of Total Therapy studies 11, 12 and 13A for childhood acute lymphoblastic leukemia at St Jude Children's Research Hospital. Leukemia. 2001; 14(12):2286-94. DOI: 10.1038/sj.leu.2401938. View

Martinez-Climent J . Molecular cytogenetics of childhood hematological malignancies. Leukemia. 1998; 11(12):1999-2021. DOI: 10.1038/sj.leu.2400842. View

Woodruff T, Axelrad D, Kyle A, Nweke O, Miller G, Hurley B . Trends in environmentally related childhood illnesses. Pediatrics. 2004; 113(4 Suppl):1133-40. View

Schumacher H, Alvares C, Blough R, Mazzella F . Acute leukemia. Clin Lab Med. 2002; 22(1):153-92, vii. DOI: 10.1016/s0272-2712(03)00071-4. View

Ma S, Chan G, Ha S, Chiu D, Lau Y, Chan L . Clinical presentation, hematologic features and treatment outcome of childhood acute lymphoblastic leukemia: a review of 73 cases in Hong Kong. Hematol Oncol. 1997; 15(3):141-9. DOI: 10.1002/(sici)1099-1069(199708)15:3<141::aid-hon608>3.0.co;2-5. View

Spirito F, Mancini M, Derme V, Cimino G, Testi A, Tafuri A . Trisomy 13 in a patient with common acute lymphoblastic leukemia: description of a case and review of the literature. Cancer Genet Cytogenet. 2003; 144(1):69-72. DOI: 10.1016/s0165-4608(02)00924-x. View

Manera R, Ramirez I, Mullins J, Pinkel D . Pilot studies of species-specific chemotherapy of childhood acute lymphoblastic leukemia using genotype and immunophenotype. Leukemia. 2000; 14(8):1354-61. DOI: 10.1038/sj.leu.2401835. View

Green E, McConville C, Powell J, Mann J, Darbyshire P, Taylor A . Clonal diversity of Ig and T-cell-receptor gene rearrangements identifies a subset of childhood B-precursor acute lymphoblastic leukemia with increased risk of relapse. Blood. 1998; 92(3):952-8. View

DAngio G, Vietti T . Old man river. The flow of pediatric oncology. Hematol Oncol Clin North Am. 2001; 15(4):599-607, vii. DOI: 10.1016/s0889-8588(05)70238-0. View

10.

Plasschaert S, Kamps W, Vellenga E, de Vries E, de Bont E . Prognosis in childhood and adult acute lymphoblastic leukaemia: a question of maturation?. Cancer Treat Rev. 2004; 30(1):37-51. DOI: 10.1016/S0305-7372(03)00140-3. View

11.

Lai R, Bueso-Ramos C . Pathologic diagnosis of acute lymphocytic leukemia. Hematol Oncol Clin North Am. 2001; 14(6):1209-35. DOI: 10.1016/s0889-8588(05)70183-0. View

12.

Downing J, Shannon K . Acute leukemia: a pediatric perspective. Cancer Cell. 2002; 2(6):437-45. DOI: 10.1016/s1535-6108(02)00211-8. View

13.

Dworzak M, Panzer-Grumayer E . Flow cytometric detection of minimal residual disease in acute lymphoblastic leukemia. Leuk Lymphoma. 2003; 44(9):1445-55. DOI: 10.3109/10428190309178763. View

14.

Mertens A, Wen W, Davies S, Steinbuch M, Buckley J, Potter J . Congenital abnormalities in children with acute leukemia: a report from the Children's Cancer Group. J Pediatr. 1998; 133(5):617-23. DOI: 10.1016/s0022-3476(98)70100-3. View

15.

Rubnitz , Pui . Childhood Acute Lymphoblastic Leukemia. Oncologist. 1997; 2(6):374-380. View

16.

Zipursky A, Poon A, Doyle J . Leukemia in Down syndrome: a review. Pediatr Hematol Oncol. 1992; 9(2):139-49. DOI: 10.3109/08880019209018329. View

17.

Pinkel D, Woo S . Prevention and treatment of meningeal leukemia in children. Blood. 1994; 84(2):355-66. View

18.

Jeha S, Gandhi V, Chan K, McDonald L, Ramirez I, Madden R . Clofarabine, a novel nucleoside analog, is active in pediatric patients with advanced leukemia. Blood. 2003; 103(3):784-9. DOI: 10.1182/blood-2003-06-2122. View

19.

Pui C . Acute lymphoblastic leukemia. Pediatr Clin North Am. 1997; 44(4):831-46. DOI: 10.1016/s0031-3955(05)70532-0. View

20.

Kolb E, Steinherz P . A new multidrug reinduction protocol with topotecan, vinorelbine, thiotepa, dexamethasone, and gemcitabine for relapsed or refractory acute leukemia. Leukemia. 2003; 17(10):1967-72. DOI: 10.1038/sj.leu.2403097. View